Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma
Authors:
- 12 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 24 (1) , 50-57
Abstract
No abstract availableKeywords
Funding Information
- Toranomon Hospital (2018-2019)
This publication has 22 references indexed in Scilit:
- Discrepancy Between Recurrence-Free Survival and Overall Survival in Patients with Resectable Colorectal Liver Metastases: A Potential Surrogate Endpoint for Time to Surgical FailureAnnals of Surgical Oncology, 2014
- Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: Comparative effectiveness of treatment modalitiesSurgery, 2012
- Survival Analysis of Re‐resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular CarcinomaWorld Journal of Surgery, 2011
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated VersionDigestive Diseases, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatmentHepatology Research, 2009
- Repeat Liver Resection for Hepatocellular CarcinomaJournal of the American College of Surgeons, 2001
- Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinomaBritish Journal of Surgery, 1999
- Surgery for small liver cancersSeminars in Surgical Oncology, 1993
- Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating CirrhosisAnnals of Surgery, 1991